Question

Difficulty: HardOrdering Imaging Studies

A 6464-year-old man is evaluated in the emergency department for severe right upper quadrant abdominal pain, nausea, and dark urine that began 2424 hours ago. He has a history of essential hypertension, type 2 diabetes mellitus, and profound sensorineural hearing loss for which he underwent bilateral cochlear implant placement 55 years ago. His temperature is 37.4∘C37.4^\circ\text{C} (99.3∘F99.3^\circ\text{F}), blood pressure is 138/85 mm Hg138/85 \text{ mm Hg}, and pulse is 88 /min88\text{ /min}. Physical examination reveals scleral icterus and tenderness to palpation in the right upper quadrant without guarding or rebound. Laboratory studies show:

Leukocyte count: 9,500 /mm39,500\text{ /mm}^3
Total bilirubin: 2.8 mg/dL2.8 \text{ mg/dL}
Direct bilirubin: 2.0 mg/dL2.0 \text{ mg/dL}
Alkaline phosphatase: 310 U/L310 \text{ U/L}
Aspartate aminotransferase (AST): 145 U/L145 \text{ U/L}
Alanine aminotransferase (ALT): 160 U/L160 \text{ U/L}

Right upper quadrant transabdominal ultrasound demonstrates multiple echogenic foci with posterior acoustic shadowing in the gallbladder. The common bile duct is dilated at 9 mm9 \text{ mm}, but the distal portion is obscured by overlying bowel gas, and no ductal stones are visualized.

Which of the following is the most appropriate next step in imaging or evaluation for this patient?

  1. Endoscopic ultrasoundAnswer
  2. B
    Magnetic resonance cholangiopancreatography
  3. C
    Endoscopic retrograde cholangiopancreatography
  4. D
    Computed tomography of the abdomen with intravenous contrast
  5. E
    Hepatobiliary iminodiacetic acid (HIDA) scan

Answer

Endoscopic ultrasound is the most appropriate next step for this patient with intermediate-risk choledocholithiasis and an absolute contraindication to MRI.
The correct response is Endoscopic ultrasound. This patient presents with signs and symptoms highly suggestive of choledocholithiasis. According to the American Society for Gastrointestinal Endoscopy (ASGE) guidelines, risk stratification dictates the next steps. This patient lacks high-risk indicators (e.g., acute ascending cholangitis, total bilirubin >4.0 mg/dL> 4.0 \text{ mg/dL}, or direct visualization of a stone on ultrasound) but has intermediate-risk indicators (dilated common bile duct, elevated liver biochemical tests, age >55> 55). For intermediate-risk patients, the recommended next step is non-invasive or lower-risk diagnostic imaging with Magnetic Resonance Cholangiopancreatography (MRCP) or Endoscopic Ultrasound (EUS) to confirm the presence of a stone before subjecting the patient to the procedural risks of Endoscopic Retrograde Cholangiopancreatography (ERCP). Because this patient has a cochlear implant, which is a strong contraindication to magnetic resonance imaging, MRCP cannot be safely performed. Therefore, Endoscopic ultrasound is the most appropriate and safest next diagnostic step.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and laboratory results.
The patient has biliary colic symptoms, jaundice, elevated liver enzymes (cholestatic pattern), a dilated common bile duct (9 mm9 \text{ mm}), and gallbladder stones, but no signs of overt acute ascending cholangitis.
This establishes the differential diagnosis, with choledocholithiasis being the primary concern.
2
Determine the risk probability for choledocholithiasis based on established guidelines (e.g., ASGE).
The patient meets criteria for 'intermediate probability' (abnormal LFTs, age > 55, dilated CBD on ultrasound, bilirubin between 1.81.8 and 4.0 mg/dL4.0 \text{ mg/dL}).
Risk stratification dictates the immediate management pathway (low risk = cholecystectomy; intermediate risk = advanced imaging; high risk = therapeutic ERCP).
3
Identify the standard imaging modalities indicated for intermediate-probability choledocholithiasis.
Standard guidelines recommend evaluating with Magnetic Resonance Cholangiopancreatography (MRCP) or Endoscopic Ultrasound (EUS).
These modalities are highly sensitive and avoid the complication risks of an invasive ERCP when the probability of a stone is not definitively high.
4
Evaluate patient-specific medical history for imaging contraindications.
The patient has bilateral cochlear implants.
Most cochlear implants contain a magnetic component that makes MRI/MRCP strictly contraindicated due to severe risks of implant displacement, tissue damage, or loss of device function.
5
Select the optimal imaging modality taking contraindications into account.
Endoscopic ultrasound (EUS) is chosen.
EUS offers equivalent sensitivity to MRCP for detecting common bile duct stones and is safe to perform in patients with non-MRI-compatible implants.

Key Concept

Patients with an intermediate probability of choledocholithiasis require advanced non-invasive diagnostic imaging (MRCP or EUS) prior to ERCP; EUS is the modality of choice when MRCP is contraindicated.
Estimated Time:1m 30s
Rate this question